Sort   by:  
 Page size 
0
UnknownMutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations.
Not available
S-EPMC1180409 | biostudies-literature
0
UnknownSMAD4 mutations found in unselected HHT patients.
Not available
S-EPMC2563178 | biostudies-literature
0
UnknownADAM12: a genetic modifier of preclinical peripheral arterial disease.
Not available
S-EPMC4591412 | biostudies-other
0
UnknownPilot investigation of circulating angiogenic and inflammatory biomarkers associated with vascular malformations.
Not available
S-EPMC8414780 | biostudies-literature
0
UnknownCardiac Troponin I-Interacting Kinase Affects Cardiomyocyte S-Phase Activity but Not Cardiomyocyte Proliferation.
Not available
S-EPMC9839600 | biostudies-literature
0
UnknownPredictors of mortality in patients with hereditary hemorrhagic telangiectasia.
Not available
S-EPMC7789194 | biostudies-literature
0
UnknownNovel Murine Models of Cerebral Cavernous Malformations.
Not available
S-EPMC7530029 | biostudies-literature
0
UnknownTranscriptomic signatures of individual cell types in cerebral cavernous malformation.
Not available
S-EPMC10775676 | biostudies-literature
0
UnknownmTORC1 Inhibitor Rapamycin Inhibits Growth of Cerebral Cavernous Malformation in Adult Mice.
Not available
S-EPMC10599232 | biostudies-literature
0
UnknownBiomarkers of cavernous angioma with symptomatic hemorrhage.
Not available
S-EPMC6629090 | biostudies-literature
Sort   by:  
 Page size